Kaya Ltd

Kaya Ltd Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kaya Ltd

₹ 248 -1.32%
05 Jun - close price
kaya.in BSE: 539276 NSE: KAYA
About

Incorporated in 2003, Kaya Ltd provides
Skin and Hair care products & services[1]

Key Points

Business Overview:[1]
KL started as a division of Marico Limited
and later emerged as a separate entity. Currently, the promoter group owns a 59.93% stake in Kaya. The company is engaged in providing skincare and hair care solutions through a range of clinics across India and the Middle East.

Website BSE NSE
  • Market Cap ₹ 377 Cr.
  • Current Price ₹ 248
  • High / Low ₹ 488 / 224
  • Stock P/E
  • Book Value ₹ -101
  • Dividend Yield 0.00 %
  • ROCE -45.5 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -4.15% over past five years.
  • Promoter holding has decreased over last 3 years: -8.50%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Consumer Discretionary Consumer Services Leisure Services Wellness

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
93 60 51 54 52 52 53 58 55 53 54 60 56
117 53 41 44 117 46 47 53 53 49 57 71 68
Operating Profit -25 6 10 11 -65 6 6 5 2 4 -3 -11 -13
OPM % -27% 10% 19% 20% -126% 11% 11% 8% 3% 7% -6% -19% -23%
1 -1 -6 -4 -18 113 -4 16 9 1 4 -4 6
Interest 17 6 6 7 7 7 8 8 8 8 9 9 9
Depreciation 16 10 9 9 9 9 9 10 9 10 11 12 12
Profit before tax -56 -10 -12 -9 -99 103 -16 4 -7 -14 -19 -36 -28
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
-56 -10 -12 -9 -99 103 -16 4 -7 -14 -19 -36 -28
EPS in Rs -43.15 -7.88 -8.91 -6.86 -75.96 78.61 -11.96 2.81 -5.36 -10.76 -12.35 -23.41 -18.28
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
332 370 409 400 421 393 275 324 377 205 217 222
296 352 425 399 408 338 248 305 395 241 198 246
Operating Profit 37 18 -16 1 13 56 27 19 -19 -36 20 -24
OPM % 11% 5% -4% 0% 3% 14% 10% 6% -5% -17% 9% -11%
11 12 10 9 4 9 15 12 5 -31 134 7
Interest 4 4 5 7 9 22 19 21 42 27 32 36
Depreciation 12 17 20 24 29 75 60 78 61 35 38 44
Profit before tax 32 9 -31 -20 -21 -33 -37 -68 -116 -130 84 -96
Tax % 0% 0% -8% -2% -26% 64% 0% 0% 0% 0% 0% 0%
32 9 -28 -20 -16 -54 -37 -68 -116 -130 84 -96
EPS in Rs 6.82 -22.23 -16.22 -12.22 -41.66 -29.10 -52.69 -89.15 -98.91 63.89 -63.32
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -5%
5 Years: -4%
3 Years: -16%
TTM: 2%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 6%
TTM: -215%
Stock Price CAGR
10 Years: -11%
5 Years: -8%
3 Years: -10%
1 Year: -26%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.00 13 13 13 13 13 13 13 13 13 13 15
Reserves 222 238 216 197 145 69 41 -15 -117 -240 -153 -168
0 0 30 25 35 167 160 204 249 301 256 296
151 155 187 136 176 160 153 159 225 221 120 135
Total Liabilities 373 407 445 372 368 409 368 361 370 295 237 278
112 149 193 201 206 303 279 240 217 174 158 193
CWIP 3 2 2 1 1 1 1 2 2 1 1 0
Investments 152 88 72 20 14 19 11 26 21 29 4 39
105 167 179 149 147 86 77 93 130 91 74 46
Total Assets 373 407 445 372 368 409 368 361 370 295 237 278

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
29 5 -8 -12 22 47 32 30 63 39 1 21
-16 -5 -39 24 -28 -12 4 -34 -39 -8 25 -63
-0 -0 33 -7 5 -47 -31 12 -18 -38 -37 37
Net Cash Flow 13 0 -13 5 -1 -11 5 8 5 -7 -11 -6
Free Cash Flow -7 -37 -34 -45 -12 38 29 15 39 5 -12 -20
CFO/OP 82% 27% 51% -795% 151% 78% 117% 158% -335% -109% 6% -86%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 0 1 2 3 5 5 4 4 3 7 4 1
Inventory Days 419 492 493 746 614 644
Days Payable 360 349 339 1,303 335 409
Cash Conversion Cycle 60 144 156 3 5 5 4 4 3 -550 283 235
Working Capital Days -80 -27 -81 -52 -86 -112 -170 -160 -175 -408 -147 -167
ROCE % 2% -12% -7% -6% -5% -8% -23% -44% -62% -2% -45%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Kaya Clinics (India)
Number ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of Kaya Clinics (Middle East)
Number ・Standalone data
Number of Dermatologists (Group)
Number
Revenue Contribution from Kaya Smiles
Percentage ・Standalone data
Average Ticket Size (India)
INR ・Standalone data
Average Ticket Size (Middle East)
USD ・Standalone data
Kaya Smiles Membership Count
Number ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
59.93% 59.93% 59.93% 59.79% 59.79% 59.64% 59.64% 59.64% 59.64% 51.43% 51.43% 51.43%
0.80% 0.81% 0.73% 0.74% 1.25% 1.27% 1.27% 1.49% 0.95% 0.63% 0.63% 0.68%
1.34% 1.34% 1.34% 1.97% 3.53% 3.61% 3.37% 1.71% 2.09% 2.53% 2.79% 2.95%
37.94% 37.91% 38.01% 37.49% 35.44% 35.48% 35.72% 37.17% 37.32% 45.40% 45.15% 44.93%
No. of Shareholders 23,03422,38421,77420,89021,47720,02819,80419,83719,57418,72418,29517,932

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls